Matthew D. Young, MD

Boston, MA ● +1-401-***-**** ● actofr@r.postjobfree.com

See next page for Volunteer Experience/Publications/Presentations EDUCATION

Alpert School of Medicine, Brown University, Providence, RI Graduated: May 2014 Doctorate of Medicine

§ Early admittance as college sophomore

§ Primary areas of focus included reconstructive plastics, oncology and orthopedics College of Engineering, University of Rhode Island, Kingston, RI Graduated: May 2009 B.S. Biomedical Engineering / B.S. Electrical Engineering

§ National award, Eta Kappa Nu; most outstanding electrical engineering student in the nation, 2009

§ Summa cum laude, highest academically ranked student in both degree programs EXPERIENCE

Monitor Deloitte, Boston, MA (November 2014 – Present) Senior Consultant; global health provider and life science strategy consulting

§ Developed cross-industry strategies leveraging the drivers, opportunities, and challenges key industry players are facing as the market shifts towards value based care (e.g., nationally recognized ACO's, health plans, PBM's, med tech companies, device manufactures, and pharma)

§ Emerged as a thought leader in mobile health (mHealth) and the Internet of Things (IoT), vigorously expanding network of KOLs, participating in national conferences, and designing go-to-market strategies

§ Effectively managed several engagements, leading teams to deliver clients efficient, comprehensive, and impactful solutions in areas such as managed care, EMR sharing, strengthening ACO affiliated relationships, population health management, market assessments, health plan integration, clinical trial data transparency, global medical affairs, customer segmentations, and predictive modeling

§ Developed web based, quantitative analytic tools for clinical trial design, pipeline maturation, and forecasting of potential market opportunities to combat sales cliff follow loss of exclusivity LabCentral, Cambridge, MA (May 2014 – November 2014) Director of Strategic Development; life-science business development

§ Developed model to evaluate emerging life science markets highlighting areas such as innovator collision, alignment with major pharmaceutical companies, and activity of major investment funds

§ Navigated the national and state life-science ecosystem, networking with federal, state, and local government's, economic development teams, philanthropists, venture capitalists, industry sponsors, and lobbyist groups

§ Optimized market opportunities by seeking out creative financing options (e.g., EB-5, new market/manufacturing tax credits, federal and state life-science/innovation grants, industrial building credits) The Brown Group/UBS Financial, Newport, RI (June 2009 – November 2014) Consultant; life-science investing

§ Leveraged market research alongside qualitative patent and FDA trial analysis to develop algorithm driven, derivative based investment strategies, notably PCYC, VRTX, REGN, ISIS

§ Created custom analytics to apply office investment history into goal oriented, future strategies AnchorsUP.org, Providence, RI (April 2014 – November 2014) Founder; life-science business development and entrepreneurship

§ Created online resource to showcase health technology companies and resources to grow businesses in Rhode Island

§ Compiled insights through over 100 interviews with company founders, public and academic leaders, family investment offices, select special interest groups, and investment fund managers Agilis Health, Boston, MA (Nov 2012 – Feb 2014)

Cofounder; mobile healthcare

§ Raised substantial investment and co-developed mobile based, algorithm driven, healthcare screening applications Replive, Boston, MA (February 2013 – April 2013)

Cofounder; medical technology tech

§ Designed a suite of portable, HIPPA compliant virtual experiences to replace the need for on-site, device representatives Slater Biotechnology Venture Fund, Providence, RI (Jan 2009 - Jan 2010) Fellow; biotechnology focused venture capital investing

§ Analyzed, improved and implemented commercialization strategies for seed stage biotechnology companies involved in diabetes care, wound healing, oncology, and fracture healing NABsys, Providence, RI (Fall 2008 – Spring 2009)

Engineer; biomedical design

§ Optimized bio-amplifier as part of the x-prize genome project Matthew D. Young, MD

Boston, MA ● +1-401-***-**** ● actofr@r.postjobfree.com VOLUNTEER EXPERIENCE

§ Walter Reed Army Medical Center, Washington, DC – Soldier rehabilitation, Wounded Warriors’ Clinic

§ Sail to Prevail, Newport, RI – Promoted independence in children with neuromuscular and genetic disabilities PUBLICATIONS

§ M.D. Young, A. Daniels, P. Evangelista, S. Reinert, S. Ritterman, M. Christino, N. Thakur, C. Born: Evaluation of the utility of the Wells score for predicting pulmonary embolus in patients admitted to the orthopaedic trauma service. Orthopedics. 36(5):e642-7, 2013 May 1.

§ M.D. Young, N. Tran, P. Tran, J.D. Jarrel, R. Hayda, C.T. Born: Niobium Oxide-Polydimethylsiloxane Hybrid Composite Coatings for Tuning Primary Fibroblast Functions, Journal of Biomedical Materials Part A, Accepted, awaiting publication

§ J. Jarrell, N. Thomas, M. Young, C. Baker, J. Morgan, P. Tran, N. Tran, R. Hayda, C. Born. Bioactive Hybrid Material Surface Treatments for Infection Resistant Implants without Drugs, ASM, Medical Device Materials VI, Proceedings from the Materials and Processes for Medical Devices Conference, August 8–10, 2011, Minneapolis, Minnesota, USA, pg 143-148

§ J. Jarrell, J. Walters, N. Thomas, M. Young, P. Tran, N. Tran, R. Hayda, C. Born. Improving the Bioresponse to Polymers using Zirconium and Tantalum Hybridization, ASM, Medical Device Materials VI, Proceedings from the Materials and Processes for Medical Devices Conference, August 8–10, 2011, Minneapolis, Minnesota, USA, pg 74-79.

§ N. Tran, T. Phong, J.D. Jarrel, J. Engiles, M.D. Young, N. Thomas, R. Hayda, C.T. Born: In vivo Caprine Model for Osteomyelitis and Evaluation of Biofilm Resistant Intramedullary Nails. BioMed Research International, vol. 2013(2013), article id. 674378.

§ C McCourt, M Young, J Schwartz, W Young, P DiSilvestro, L Brard, T Tejada-Berges, AM Bradley, DS Dizon. Factors associated with response to Taxanes as a later-line treatment of recurrent ovarian cancer. Society of Gynecologic Oncologists Annual Meeting, San Diego, CA. March 4-5, 2007.

§ C McCourt, S Dessie, DS Dizon, M Young, L Brard, R Legare, B Sakr, P DiSilvestro. Platinum-free, Taxane-free, Or Treatment Free Interval: Which Predicts Response to Taxane Therapy As Third or Later Line Treatment? 2008 Society of Gynecologic Oncologists Annual Meeting, Tampa, FL. March 8-12, 2008.

§ N. Tran, P Tran, JD Jarrell, J Engiles, N Thomas, M Young, R Hayda, C Born: Development of a Goat Model of Osteomyelitis for the Assessment of Bacterial Resistant Intramedullary Nailing Systems. BioMed Research International.

§ N. Tran, P Tran, JD Jarrell, J Engiles, N Thomas, M Young, R Hayda, C Born: Development of a Goat Model of Osteomyelitis for the Assessment of Bacterial Resistant Intramedullary Nailing Systems. BioMed research International. POSTER PRESENTATIONS

§ Young MD, Daniels AH, Evangelista PT, Reinert SE, Ritterman S, Christino MA, Thakur NA, Born CT: Evaluation of the utility of the Wells score for predicting pulmonary embolus in patients admitted to the orthopaedic trauma service. Paper presented at: MAOA 2013. Proceedings of the 31st Annual Meeting; 2013 April 17-21; Amelia Island, FL.

§ Young MD, Heard W, Paller D, Kane P, Vopat B,, Born CT, Thakur NA: Inferior lag screw placement: does tip, apex distance really matter?. Paper presented at: OTA 2012. OTA Annual Meeting; 2012 October 4-6; Minneapolis, MN

§ Young MD, Daniels AH, Evangelista PT, Reinert SE, Ritterman S, Christino MA, Thakur NA, Born CT: Evaluation of the utility of the Wells score for predicting pulmonary embolus in patients admitted to the orthopaedic trauma service. Paper presented at: Lifespan Research Celebration 2012. 20th Annual hospital research celebration; 2012October11;Providence, RI.

§ Young MD, Tran N, Jarrell J, Hayda R, Born CT: Effects of niobium oxide coatings for implantable materials on primary fibroblast growth. Poster presented at: AMA 2011; 9th Annual AMA Medical Student Section and Resident and Fellow Section Research Symposium; 2011 Nov 10-12; New Orleans, LA.

Contact this candidate